Opinion: Separate Training from Research Budgets

In order to make the most of biomedical research funding and to better support trainees, institutions should recognize postdocs as employees.

Written byViviane Callier
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, PEN WAGGENEROver the past three decades, the number of postdoctoral researchers in biomedical science has increased about three-fold, but jobs in industry and academic research have not kept pace with this increase. At the same time, PhD education and postdoctoral training in the sciences has become increasingly exploitative.

Postdocs carry out the brunt of the scientific research at American research universities. They are at a career stage when they have enough experience to make important contributions and are often the cutting edge of their fields. Yet many are institutionally invisible—counting neither as students nor as staff, and thus often not receiving salary, health insurance or retirement plans comparable to university staff. Many institutions cannot even state how many postdocs they employ. Postdocs are treated as transient satellites, often supported on short-term contracts.

Many young scientists train for over a decade to develop highly specialized technical skills, only to find that there are no jobs that match their training, and that they must repurpose themselves for other careers. Today, fewer than 10 percent of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Viviane was a Churchill Scholar at the University of Cambridge, where she studied early tetrapods. Her PhD at Duke University focused on the role of oxygen in insect body size regulation. After a postdoctoral fellowship at Arizona State University, she became a science writer for federal agencies in the Washington, DC area. Now, she freelances from San Antonio, Texas.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies